Serial Number
79441971
Owner
MEDIOLANUM FARMACEUTICI S.p.A.Attorney
John ZaccariaFiling Date
Nov 19, 2025
VALALTO Trademark
Serial Number: 79441971
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 41 - Education & Entertainment
Education; providing of training; entertainment; sporting and cultural activities
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
VIA S.G. Cottolengo 15/31
20143 Milano , IT
Entity Type: 99
Legal Representation
Correspondence Address
John Zaccaria Notaro, Michalos & Zaccaria P.C.
100 Dutch Hill Road, Suite 240
Orangeburg, NY 10962
United States
Trademark Details
Filing Date
November 19, 2025
Registration Date
Not Registered
Goods & Services
Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; marketing services; advertising services
Arranging and conducting of in-person educational forums in the field of pharmaceuticals; Educational services in the nature of pharmaceuticals schools; providing information in the field of education; providing online electronic publications, not downloadable, namely, brochures in the field of pharmaceuticals; arranging and conducting of conferences in the field of pharmaceuticals; arranging and conducting of congresses in the field of pharmaceuticals; arranging and conducting of colloquiums in the field of pharmaceuticals; arranging and conducting of seminars in the field of pharmaceuticals; arranging and conducting of symposiums in the field of pharmaceuticals
Dietetic foods adapted for medical purposes; teeth filling material; herbicides; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; pharmaceutical preparations for the treatment of neuroendocrine disorders; fungicides; food for babies; dietetic substances in the nature of dietetic foods adapted for medical use; disinfectants; nutritional supplements for medical purposes; homogenized food adapted for medical purposes; analgesics; anaesthetics; antibiotics; anti-inflammatories; Food supplements, namely, anti-oxidants; dietetic beverages adapted for medical purposes; vitamin supplement patches; dietary fibre supplements; glycerine for medical purposes; immunostimulants; protein dietary supplements; mineral dietary supplements; dietary supplements for human beings; medicated lotions for pharmaceutical purposes; narcotics being pharmaceuticals for the treatment of pain; opiates being pharmaceuticals for the treatment of pain; Pharmaceutical preparations in the form of pastilles for the treatment of cancer; Pharmaceutical preparations in the form of pastilles for the treatment of pain; Pharmaceutical preparations in the form of pastilles for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; Pharmaceutical preparations in the form of pastilles for the treatment of neuroendocrine disorders; chemical preparations for pharmaceutical purposes for the treatment of cancer; chemical preparations for pharmaceutical purposes for the treatment of pain; chemical preparations for pharmaceutical purposes for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; chemical preparations for pharmaceutical purposes for the treatment of neuroendocrine disorders; chemical preparations for medical purposes for the treatment of cancer; chemical preparations for medical purposes for the treatment of pain; chemical preparations for medical purposes for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; chemical preparations for medical purposes for the treatment of pain; chemical preparations for medical purposes for the treatment of neuroendocrine disorders; Aloe vera preparations for pharmaceutical purposes; phytotherapy preparations for medical purposes; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer-related conditions; vitamin preparations; chemico-pharmaceutical preparations for the treatment of cancer; chemico-pharmaceutical preparations for the treatment of pain; chemico-pharmaceutical preparations for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; chemico-pharmaceutical preparations for the treatment of neuroendocrine disorders